(Q51053038)

English

RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.

scientific article published in August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

1 reference

based on heuristic

inferred from title

author name string

A Krause

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

W Z Whu

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

J Qiu

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

D Wafadari

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

N R Hackett

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

A Sharma

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

R G Crystal

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

S Worgall

8

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

173

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

230-241

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

Vaccines and immunotherapy against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Pseudomonas immunotherapy: a historical overview

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Pseudomonas aeruginosa: the potential to immunise against infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Recent developments for Pseudomonas vaccines

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Outer Membrane Proteins of Pseudomonas aeruginosa Serotype Strains

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Recognition of host immune activation by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Neutralizing antibodies against 33 human adenoviruses in normal children in Rome

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Development of nonhuman adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Novel adenovirus vector-based vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

New insights on adenovirus as vaccine vectors

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Vaccination strategies to promote mucosal antibody responses.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenovirus vector-mediated gene transfer to regional lymph nodes

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Lung dendritic cells at the innate-adaptive immune interface

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Intracellular trafficking of adenovirus: many means to many ends

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Cystic fibrosis: a mucosal immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Lung infections associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Comparative biology of cystic fibrosis animal models

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Delivery of antigens by viral vectors for vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Intrapleural 'outside-in' gene therapy: therapeutics for organs of the chest via gene transfer to the pleura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Circumventing the immune response to adenovirus-mediated gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of antimicrobial resistance in bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 i

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular immune responses of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CEI.12101

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51053038&oldid=1418429572"